Archimedes Tech SPAC Partners II Co.
ATIINasdaqFinancials · Blank Checks · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | |
|---|---|---|
| Revenue | — | — |
| Operating income | −$785,975 | −$78,700 |
| Net income | $8.0M | −$78,700 |
| Total assets | $241.3M | $429,691 |
| Total liabilities | $8.2M | $483,391 |
| Equity | −$6.7M | $0 |
| EPS (diluted) | — | $-0.02 |
| Shares out. | 29.6M | 5.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −119.1%
- Return on assets
- 3.3%
- Return on capital (ROCE)
- −0.3%
- Liabilities / assets
- 3.4%
- Debt / equity
- —
- Book value / share
- $-0.23
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.94distress
- Accruals / assets
- 3.6%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Barclays PlcPassive (13G)Feb 11, 2026
- Tenor Capital Management Co., L.P.Passive (13G)Nov 7, 2025
- Sculptor Capital LpPassive (13G)Aug 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 54,969 | 1.0 | +532.8% |
| Apr 30, 2026 | 8,687 | 1.0 | +344.1% |
| Apr 15, 2026 | 1,956 | 1.0 | -5.2% |
| Mar 31, 2026 | 2,063 | 1.0 | -15.5% |
| Mar 13, 2026 | 2,442 | 1.0 | -61.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureApr 30, 2026
- Regulation FD disclosureApr 22, 2026
- Entered a material agreement · Unregistered equity sale · Regulation FD disclosureApr 20, 2026
- Other material eventMar 31, 2025
- Other material eventFeb 19, 2025
- Entered a material agreement · Unregistered equity sale · Amended charter or bylaws · Other material eventFeb 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QFORM 10-QMay 14, 2026
- 425May 8, 2026
- 425FORM 425Apr 30, 2026
- 8-KFORM 8-KApr 30, 2026
- 425FORM 425Apr 23, 2026
- 425FORM 425Apr 22, 2026
- 8-KFORM 8-KApr 22, 2026
- 425FORM 425Apr 21, 2026
- 8-KFORM 8-KApr 20, 2026
- 10-KFORM 10-KMar 4, 2026
- SCHEDULE 13G/AFeb 11, 2026
- 10-QFORM 10-QNov 7, 2025
- SCHEDULE 13G/ANov 7, 2025
- SCHEDULE 13G/AAug 14, 2025
- SCHEDULE 13GAug 12, 2025